Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Energy Drink Plans Earn Durbin’s Stamp; Firms Meet With Agency

This article was originally published in The Tan Sheet

Executive Summary

Senate critics say FDA “is moving forward in a number of areas to protect vulnerable populations against high levels of caffeine in energy drinks.” Monster Energy and Rockstar representatives tell FDA their products are safe. Rep. Markey asks FTC to scrutinize advertising for the products.

You may also be interested in...



Congressional Energy Drink Report Pushes Voluntary Industry Actions

Legislators want energy drink makers to rein in their marketing and labeling practices, while pressing FDA and FTC to use existing regulatory authority against the products. History suggests legislation in this area would be hard-pressed to gain traction.

Congressional Energy Drink Report Pushes Voluntary Industry Actions

Legislators want energy drink makers to rein in their marketing and labeling practices, while pressing FDA and FTC to use existing regulatory authority against the products. History suggests legislation in this area would be hard-pressed to gain traction.

Trade Groups Expand Caffeine Labeling To Stave Off Tighter Regs

The Council for Responsible Nutrition and the American Herbal Products Association amend guidelines and requirements for labeling and marketing caffeine-containing products, going beyond the law in response to congressional and public health complaints about the ingredient’s safety.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106133

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel